Abstract
Common forms of Parkinson's disease have long been described as idiopathic, with no single penetrant genetic factor capable of influencing disease aetiology. Recent genetic studies indicate a clear association of variants within several lysosomal genes as risk factors for idiopathic Parkinson's disease. The emergence of novel variants suggest that the aetiology of idiopathic Parkinson's disease may be explained by the interaction of several partially penetrant mutations that, while seemingly complex, all appear to converge on cellular clearance pathways. These newly evolving data are consistent with mechanistic studies linking α-synuclein toxicity to lysosomal abnormalities, and indicate that idiopathic Parkinson's disease resembles features of Mendelian lysosomal storage disorders at a genetic and biochemical level. These findings offer novel pathways to exploit for the development of diseasealtering therapies for idiopathic Parkinson's disease that target specific components of the lysosomal system.
Original language | English (US) |
---|---|
Pages (from-to) | 2255-2262 |
Number of pages | 8 |
Journal | Brain |
Volume | 141 |
Issue number | 8 |
DOIs | |
State | Published - Aug 1 2018 |
Funding
A.D.K. is funded by Fondo Nacional de Desarrollo Científico y Tecnológico grant No 1180337 and by the European Union’s Horizon 2020 research and innovation programme (RISE) under the Marie Sklodowska-Curie grant agreement No 734825. J.R.M. is supported by the National Institute of Neurological Disorders and Stroke grant R01NS092823.
ASJC Scopus subject areas
- Clinical Neurology